Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status.

[1]  Robin J. Leach,et al.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.

[2]  A. Look,et al.  Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. , 1993, Cancer research.

[3]  S. Stass,et al.  The human MDM-2 oncogene is overexpressed in leukemias. , 1993, Blood.

[4]  N. Muñoz,et al.  p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. , 1993, The American journal of pathology.

[5]  H. Kovar,et al.  Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours. , 1993, Oncogene.

[6]  A. Levine,et al.  Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. , 1993, Oncogene.

[7]  D. Louis,et al.  Accumulation of wild type p53 protein in human astrocytomas. , 1993, Cancer research.

[8]  B. Quesnel,et al.  Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes. , 1993, Leukemia.

[9]  M. Sheikh,et al.  The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma. , 1993, Cancer research.

[10]  A. Levine,et al.  The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.

[11]  G. Reifenberger,et al.  Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. , 1993, Cancer research.

[12]  P. Meltzer,et al.  p53 Mutation and MDM2 amplification in human soft tissue sarcomas. , 1993, Cancer research.

[13]  Bert Vogelstein,et al.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.

[14]  H. Sakamoto,et al.  Amplified genes in cancer in upper digestive tract. , 1993, Seminars in cancer biology.

[15]  C. Finlay,et al.  The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth , 1993, Molecular and cellular biology.

[16]  D. Lane,et al.  Abnormal expression of wild type p53 protein in normal cells of a cancer family patient , 1992, The Lancet.

[17]  P. Meltzer,et al.  Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.

[18]  A. Levine,et al.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.

[19]  D. George,et al.  Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. , 1991, The EMBO journal.

[20]  M. Key,et al.  Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[21]  H. J. Evans,et al.  Mutations in p53 do not account for heritable breast cancer: a study in five affected families. , 1991, British Journal of Cancer.

[22]  Kathleen R. Cho,et al.  Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.

[23]  U. Francke,et al.  Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line , 1987, Somatic cell and molecular genetics.

[24]  M. Ladanyi,et al.  MDM2 gene amplification in metastatic osteosarcoma. , 1993, Cancer research.

[25]  B. Ponder,et al.  No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families. , 1992, Oncogene.